A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells - PubMed (original) (raw)
. 2003 Nov;88(11):5119-26.
doi: 10.1210/jc.2003-030222.
Affiliations
- PMID: 14602737
- DOI: 10.1210/jc.2003-030222
A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells
Xun Zhang et al. J Clin Endocrinol Metab. 2003 Nov.
Abstract
Human pituitary adenomas are the most common intracranial neoplasm. Typically monoclonal in origin, a somatic mutation is a prerequisite event in tumor development. To identify underlying pathogenetic mechanisms in tumor formation, we compared the difference in gene expression between normal human pituitary tissue and clinically nonfunctioning pituitary adenomas by cDNA-representational difference analysis. We cloned a cDNA, the expression of which was absent in these tumors, that represents a novel transcript from the previously described MEG3, a maternal imprinting gene with unknown function. It was expressed in normal human gonadotrophs, from which clinically nonfunctioning pituitary adenomas are derived. Additional investigation by Northern blot and RT-PCR demonstrated that this gene was also not expressed in functioning pituitary tumors as well as many human cancer cell lines. Moreover, ectopic expression of this gene inhibits growth in human cancer cells including HeLa, MCF-7, and H4. Genomic analysis revealed that MEG3 is located on chromosome 14q32.3, a site that has been predicted to contain a tumor suppressor gene involved in the pathogenesis of meningiomas. Taken together, our data suggest that MEG3 may represent a novel growth suppressor, which may play an important role in the development of human pituitary adenomas.
Comment in
- Pituitary tumor pathogenesis--the hunt for novel candidate genes continues.
Ezzat S. Ezzat S. J Clin Endocrinol Metab. 2003 Nov;88(11):5116-8. doi: 10.1210/jc.2003-031633. J Clin Endocrinol Metab. 2003. PMID: 14602736 Review. No abstract available.
Similar articles
- Hypermethylation of the promoter region is associated with the loss of MEG3 gene expression in human pituitary tumors.
Zhao J, Dahle D, Zhou Y, Zhang X, Klibanski A. Zhao J, et al. J Clin Endocrinol Metab. 2005 Apr;90(4):2179-86. doi: 10.1210/jc.2004-1848. Epub 2005 Jan 11. J Clin Endocrinol Metab. 2005. PMID: 15644399 - Selective loss of MEG3 expression and intergenic differentially methylated region hypermethylation in the MEG3/DLK1 locus in human clinically nonfunctioning pituitary adenomas.
Gejman R, Batista DL, Zhong Y, Zhou Y, Zhang X, Swearingen B, Stratakis CA, Hedley-Whyte ET, Klibanski A. Gejman R, et al. J Clin Endocrinol Metab. 2008 Oct;93(10):4119-25. doi: 10.1210/jc.2007-2633. Epub 2008 Jul 15. J Clin Endocrinol Metab. 2008. PMID: 18628527 Free PMC article. - Loss of expression of GADD45 gamma, a growth inhibitory gene, in human pituitary adenomas: implications for tumorigenesis.
Zhang X, Sun H, Danila DC, Johnson SR, Zhou Y, Swearingen B, Klibanski A. Zhang X, et al. J Clin Endocrinol Metab. 2002 Mar;87(3):1262-7. doi: 10.1210/jcem.87.3.8315. J Clin Endocrinol Metab. 2002. PMID: 11889197 - Isolation and characterization of novel pituitary tumor related genes: a cDNA representational difference approach.
Zhang X, Zhou Y, Klibanski A. Zhang X, et al. Mol Cell Endocrinol. 2010 Sep 15;326(1-2):40-7. doi: 10.1016/j.mce.2010.02.040. Epub 2010 Mar 6. Mol Cell Endocrinol. 2010. PMID: 20211686 Free PMC article. Review. - [Pituitary adenoma: mechanisms of endocrine oncogenesis].
Bertherat J, Bertagna X. Bertherat J, et al. Rev Prat. 1996 Jun 15;46(12):1473-81. Rev Prat. 1996. PMID: 8881160 Review. French.
Cited by
- Comparative transcriptome of normal and cancer-associated fibroblasts.
Abikar A, Mustafa MMS, Athalye RR, Nadig N, Tamboli N, Babu V, Keshavamurthy R, Ranganathan P. Abikar A, et al. BMC Cancer. 2024 Oct 5;24(1):1231. doi: 10.1186/s12885-024-13006-x. BMC Cancer. 2024. PMID: 39369238 Free PMC article. - Scutellarein treats neuroblastoma by regulating the expression of multiple targets.
Zhai CY, Fan JS, Zhang RP. Zhai CY, et al. Ibrain. 2023 May 13;10(3):345-355. doi: 10.1002/ibra.12100. eCollection 2024 Fall. Ibrain. 2023. PMID: 39346787 Free PMC article. - GNAS mutations suppress cell invasion by activating MEG3 in growth hormone-secreting pituitary adenoma.
Tang C, Zhong C, Zhu J, Yuan F, Yang J, Xu Y, Ma C. Tang C, et al. Oncol Res. 2024 May 23;32(6):1079-1091. doi: 10.32604/or.2024.046007. eCollection 2024. Oncol Res. 2024. PMID: 38827318 Free PMC article. - Noncoding RNA landscape and their emerging roles as biomarkers and therapeutic targets in meningioma.
Joshi R, Sharma A, Kulshreshtha R. Joshi R, et al. Mol Ther Oncol. 2024 Feb 27;32(1):200782. doi: 10.1016/j.omton.2024.200782. eCollection 2024 Mar 21. Mol Ther Oncol. 2024. PMID: 38596289 Free PMC article. Review. - Expression of lncRNAs in glioma: A lighthouse for patients with glioma.
Lu X, Zhang D. Lu X, et al. Heliyon. 2024 Jan 24;10(3):e24799. doi: 10.1016/j.heliyon.2024.e24799. eCollection 2024 Feb 15. Heliyon. 2024. PMID: 38322836 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases